| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2008 | CN101095667A Liquid for disinfecting wound and the disinfecting method thereof |
| 01/02/2008 | CN101095666A Novel hydrochloric acid tramadol sustained-release tablet |
| 01/02/2008 | CN101095665A Use of SIRT1 in the preventing, controlling and treating of fatness |
| 01/02/2008 | CN101095664A Phosphatide compound of resveratrol compounds and method for preparing the same and the application thereof |
| 01/02/2008 | CN101095663A Nicergoline sustained-release capsules and method for preparing the same |
| 01/02/2008 | CN101095661A Isosorbide mononitrate orally disintegrating tablets |
| 01/02/2008 | CN101095660A Docetaxel lyophilization dry emulsion for injections and method for preparing the same |
| 01/02/2008 | CN101095659A Liposome combined medicine and method for preparing the same |
| 01/02/2008 | CN101095658A Policresulen gelling agent, method for preparation the same and the pharmaceutical use thereof |
| 01/02/2008 | CN101095650A Use of coumarin, butylated hydroxyanisole and ethoxyquin for treating grey hair |
| 01/02/2008 | CN101095465A Application of low-polyxylose complicated preparation in the preparing of feedstuff that is capable of enhancing immunity of marine animals |
| 01/02/2008 | CN101095462A Method for synthesizing the feed additive - isoflavone |
| 01/02/2008 | CN100359015C Human tumour-derived polyptde hormone phosphatonin |
| 01/02/2008 | CN100359014C Novel epothilones compound and its preparation method and application |
| 01/02/2008 | CN100358912C Process for producing erythromycin derivative |
| 01/02/2008 | CN100358911C N-acetylglucosamine derivatives and use thereof |
| 01/02/2008 | CN100358910C Glucose phosphonic amide crystals and preparation process and use thereof |
| 01/02/2008 | CN100358901C Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/02/2008 | CN100358900C Novel compounds |
| 01/02/2008 | CN100358899C Platelet activation factor resisting compound |
| 01/02/2008 | CN100358898C Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| 01/02/2008 | CN100358897C 8-substituted-6,7,8,9-tetrahy9dropyrimido (1,2-a) pyrimidin-4-one derivatives |
| 01/02/2008 | CN100358893C Use of and some novel imidazopyridines |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
| 01/02/2008 | CN100358891C Pyranones useful as ATM inhibitors |
| 01/02/2008 | CN100358890C 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors |
| 01/02/2008 | CN100358889C Imidazol-4-yl-ethynyl-pyridine derivatives |
| 01/02/2008 | CN100358888C Novel guanidine mimics as factor Xa inhibitors |
| 01/02/2008 | CN100358878C Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 01/02/2008 | CN100358875C Fluoro-contained 1H-1,2,3-triazaazole compounds, preparation method thereof and their use |
| 01/02/2008 | CN100358874C 3,4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same |
| 01/02/2008 | CN100358872C The derivatives of pyridone and use thereof |
| 01/02/2008 | CN100358870C Aminotetralin derivatives as muscarinic receptor antagonists |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/02/2008 | CN100358862C 2,5-bis-diamine-[1,4] benzoquinone derivatives for the treatment of alzheimer's disease, a process for their preparation and intermediates therefor |
| 01/02/2008 | CN100358861C Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 01/02/2008 | CN100358595C Safety shield system for prefilled syringe |
| 01/02/2008 | CN100358580C Pharmaceutical compositions |
| 01/02/2008 | CN100358579C Compositions and methods to improve oral absorption of antimicrobial agents |
| 01/02/2008 | CN100358578C Composition for cooperative therapy and method thereof |
| 01/02/2008 | CN100358569C Cancer-treating medicine and its preparation method |
| 01/02/2008 | CN100358562C Tendril-leaved fritillary bulb loquat drop pills and preparation method thereof |
| 01/02/2008 | CN100358561C Medicinal oral liquor for nourishing Yin and tonifying stomach |
| 01/02/2008 | CN100358544C Medicine for treating psoriasis |
| 01/02/2008 | CN100358539C Quality control method for ginkgo-dipyridamine injection |
| 01/02/2008 | CN100358537C Compound povidone iodine external use medicine |
| 01/02/2008 | CN100358536C Prepn process and formula of compound chondroitin sulfate tablet |
| 01/02/2008 | CN100358535C Composition of mycobacterium polysaccharide and its preparation |
| 01/02/2008 | CN100358534C Use of malposed double-strauded oligo nucleotide for preparing medicine for treating avian flu virus infection |
| 01/02/2008 | CN100358533C Medicinal composition for drug-induced neuropathy |
| 01/02/2008 | CN100358532C Total flavone of citrus grandis osbeckvar tomentosa hort peridium, and its extracting method and use |
| 01/02/2008 | CN100358531C Glycyrrhizin drop pills and preparation method thereof |
| 01/02/2008 | CN100358530C Medicine prepn for treating cerebral apoplexy and its prepn |
| 01/02/2008 | CN100358529C Treatment of hyperproliferative disorders |
| 01/02/2008 | CN100358528C Use of mometasone furoate for treating airway passage and lung diseases |
| 01/02/2008 | CN100358527C Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 01/02/2008 | CN100358526C Composite for treating hyperlipidemia |
| 01/02/2008 | CN100358525C Prepn process of Lansoprazole sodium for treating peptic ulcer |
| 01/02/2008 | CN100358524C Aumeilazole drip pills and its preparation method |
| 01/02/2008 | CN100358523C Preparation method of paracetamol pseudoephedrine hydrochloride and cholrphenamine maleate oral disintegration tablet |
| 01/02/2008 | CN100358522C Anti-beta-lactamase antibiotic composite preparation |
| 01/02/2008 | CN100358521C Suppository of Metronidazole and preparation technique |
| 01/02/2008 | CN100358520C Edalavon powder for ampoul injection having good stability and its preparation method |
| 01/02/2008 | CN100358519C Medicine against fungus |
| 01/02/2008 | CN100358518C Pharmaceutical compositions containing terbinafin and use thereof |
| 01/02/2008 | CN100358517C Tamoxifen citrate oral disintegrating tablet and its preparation method |
| 01/02/2008 | CN100358516C Application of rugose soft sulfo-acid in anti HIV-1 virus |
| 01/02/2008 | CN100358515C Treatment of neurodegenerative and cardiovascular disorders |
| 01/02/2008 | CN100358514C Remedies for allergic eye diseases |
| 01/02/2008 | CN100358513C Disoprofol injection preparation process |
| 01/02/2008 | CN100358512C Pharmaceutical compositions comprising adenosine receptor agonist or antagonist |
| 01/02/2008 | CN100358506C Compound musk drip pill and its preparation method |
| 01/02/2008 | CN100358496C 'Xingnaojing' dripping pills for treating cephalitis and hepatic coma and preparation process thereof |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/02/2008 | CN100358435C Products containing polyphenol(S) and L-arginine to stimulate nitric oxide production |
| 01/02/2008 | CN100358427C Dairy product or drink for resisting oxidation, regulating blood , nursing heart and delaying aging |
| 01/01/2008 | USRE39993 Emulsions |
| 01/01/2008 | USRE39991 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/01/2008 | US7314959 Amino thiol compounds and compositions for use in conjunction with cancer therapy |
| 01/01/2008 | US7314956 A molecular carrier containing a central multivalent core and multiple adduct molecules bonded with core, wherein adduct represents adduct moieties which can be the same of different from one another and are residues of amino acids |
| 01/01/2008 | US7314955 Crystalline form "C"; amidating D-phenylalanine methyl ester hydrocholoride with trans-4-isopropylcyclohexane carboxylic acid in a halogenated hydrocarbon; hydrolyzing to form free acid |
| 01/01/2008 | US7314953 Treatment of lung cells with histone deacetylase inhibitors |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314939 Compositions and methods for inhibiting TGF-β |
| 01/01/2008 | US7314938 Immune and/or inflammatory disorders; autoimmune disorders; disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1); antagonize CD11/CD18 receptors associated with leukocytes. |
| 01/01/2008 | US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314935 Optically pure dihydroimidazo[1,2-h][1,7]naphthyridine intermediates for tetrahydroimidazo[1,2-h][1,7]naphthyridine gastrointestinal antisecretory agents; 7-Acetoxy-10-acetyl-2,3-dimethyl-9-phenyl-9,10-dihydroimidazo[1,2-h][1,7]naphthyridine |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314933 Vanilloid receptor ligands and their use in treatments |
| 01/01/2008 | US7314932 Methods for minimizing thioamide impurities |
| 01/01/2008 | US7314931 Chemical intermediate |
| 01/01/2008 | US7314930 Reducing 2-nitro-2'-carboxy-diphenylsulfide derivative in presence of hydrogen gas and reduction catalyst; subjecting 2-amino-2'-carboxy-diphenylsulfide derivative to dehydration-condensation to produce dibenzo[b,f][1,4]thiazepin-11-one compound |
| 01/01/2008 | US7314927 Anticode oligomer for prevention and treatment of cell proliferative disorders; antitumor, antisense, antiproliferative agents |
| 01/01/2008 | US7314926 Inhibiting cell proliferation, breast cancer, prostate cancer, cervical cancer, lung cancer, or tumor cells |
| 01/01/2008 | US7314923 The present invention relates to novel oligonucleotide analogues, which exhibit antisense or antigene activity having excellent stability, or exhibit excellent activity as a detection agent (probe) for a specific gene or as a primer |
| 01/01/2008 | US7314890 7-[[5-Hydroxy-5-(1-propylcyclobutyl)pent-2enyl] methanesulfonylamino] heptanoic acid ethyl ester; lowering intraocular pressure, glaucoma |
| 01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |